H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
Novel altruistic stem cell defense mechanism may be targeted to develop new COVID-19 vaccines

Novel altruistic stem cell defense mechanism may be targeted to develop new COVID-19 vaccines

The great promise of antiviral peptides against SARS-CoV-2

The great promise of antiviral peptides against SARS-CoV-2

New strategy for developing universal flu vaccine

New strategy for developing universal flu vaccine

Reduced birth rates during early pandemic are predicted to rebound soon

Reduced birth rates during early pandemic are predicted to rebound soon

Plant-based oil blend shows virucidal activity against SARS-CoV-2 and influenza viruses in vitro

Plant-based oil blend shows virucidal activity against SARS-CoV-2 and influenza viruses in vitro

Researchers develop rapid antibody screening method for novel COVID-19 therapeutics development

Researchers develop rapid antibody screening method for novel COVID-19 therapeutics development

Experts offer plausible solutions to mitigate zoonotic risk associated with intensive animal agriculture

Experts offer plausible solutions to mitigate zoonotic risk associated with intensive animal agriculture

Repurposed gout medication (probenecid) shows potent inhibition of SARS-CoV-2 replication

Repurposed gout medication (probenecid) shows potent inhibition of SARS-CoV-2 replication

B.1.1.7 not associated with change in serial interval of COVID-19

B.1.1.7 not associated with change in serial interval of COVID-19

Researchers identify specific influenza targets that could lead to universal flu vaccine for indigenous populations

Researchers identify specific influenza targets that could lead to universal flu vaccine for indigenous populations

Combo COVID-flu vaccine protects against current and emerging variants in animal model

Combo COVID-flu vaccine protects against current and emerging variants in animal model

Researchers develop a multivalent vaccine for COVID-19 and influenza

Researchers develop a multivalent vaccine for COVID-19 and influenza

Detecting rare blood clots was a win, but US vaccine safety system still has gaps

Detecting rare blood clots was a win, but US vaccine safety system still has gaps

Could CRISPR be used as a SARS-CoV-2 antiviral?

Could CRISPR be used as a SARS-CoV-2 antiviral?

New treatment reduces the severity of ARDS in influenza-infected mice

New treatment reduces the severity of ARDS in influenza-infected mice

Study uncovers a novel autoantigen in patients with narcolepsy type 1

Study uncovers a novel autoantigen in patients with narcolepsy type 1

Study reports on safety of COVID-19 mRNA vaccines in pregnancy

Study reports on safety of COVID-19 mRNA vaccines in pregnancy

Study explores how lessons from past crises could improve the pandemic response

Study explores how lessons from past crises could improve the pandemic response

UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research

UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research

Little evidence of COVID-19 vaccine nationalism in public opinion

Little evidence of COVID-19 vaccine nationalism in public opinion